Table 2.
Features of human LN | Spontaneous disease in lupus mice* |
---|---|
Female predominance | NZB/W F1, NZM2328 |
Serum autoantibodies | |
anti-nuclear, anti-dsDNA | All strains |
anti-Sm | MRL/lpr |
Kidney Pathology | |
Glomerular Immune complexes | All strains |
Proliferative GN | All strains |
Type V membranous nephropathy | None** |
Glomerulosclerosis | All strains |
Tubulointerstitial inflammation | All strains |
Cellular infiltrates | |
Neutrophils | NZM2328 |
Macrophages | All strains |
Dendritic cells | All strains |
NK cells | MRL/lpr |
T cells (CD4/CD8) | MRL/lpr, NZM2328, NZB/W F1 |
B cells | NZB/W F1 |
Plasma cells | NZB/W F1 |
Kidney failure*** | All strains |
Other clinical features | |
Hypertension | None reported |
Systemic involvement | skin, MRL/lpr; salivary glands, NZB/W F1 |
Abbreviations: dsDNA, double-stranded DNA; LN, lupus nephritis; NZB, New Zealand Black; NZW, NZ White; NZM, NZ Mixed; NK, natural killer; GN, glomerulonephritis.
includes NZB/W F1, NZM2410, NZM2328, MRL/lpr, BXSB strains
can be induced by immuno-modulation
elevated serum creatinine, serum urea nitrogen, proteinuria